These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants: a note of caution. Suresh S; Schilling S; Dakin C; Harris MA J Paediatr Child Health; 2003 Nov; 39(8):637. PubMed ID: 14629536 [No Abstract] [Full Text] [Related]
11. [Recommendations for the prevention of respiratory syncytial virus in high-risk pediatric groups]. Janković B; Minić P; Maglajlić-Djukić S; Prekajski N Vojnosanit Pregl; 2009 Oct; 66(10):827-9. PubMed ID: 19938762 [No Abstract] [Full Text] [Related]
12. Palivizumab for respiratory syncytial virus prophylaxis. Sandritter T J Pediatr Health Care; 1999; 13(4):191-5; quiz 196-7. PubMed ID: 10690084 [TBL] [Abstract][Full Text] [Related]
13. [Palivizumab prophylaxis against respiratory syncytial virus. Should its indications be reviewed?]. Salas Hernández S An Pediatr (Barc); 2004 Jan; 60(1):87-8. PubMed ID: 14718137 [No Abstract] [Full Text] [Related]
14. Respiratory syncytial virus: old challenges and new approaches. Chávez-Bueno S; Mejías A; Jafri HS; Ramilo O Pediatr Ann; 2005 Jan; 34(1):62-8. PubMed ID: 15693217 [TBL] [Abstract][Full Text] [Related]